Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R N JONES

Showing results (451-460 of 945) with videos related to

Pageof 95
Sort By:
Journal of Clinical Microbiology|April 1, 1992
Interpretive criteria for disk diffusion tests using 5-microgram cefdinir disks with rapidly growing clinical isolatesR N Jones, M E Erwin, B B Gooding
Diagnostic Microbiology and Infectious Disease|November 21, 1998
Activity of a broad-spectrum cephalosporin (Ro 48-8391) alone and in combination with two novel beta-lactamase inhibitors (Ro 48-5545 and Ro 48-8724)R N Jones, S A Marshall, D J Varnam
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 1, 1993
In vitro activity of E-4868, a new trifluoroquinolone, compared to six similar compoundsM S Barrett, R N Jones, M E Erwin
The Journal of Antibiotics|September 1, 1977
In vitro antimicrobial activity comparison of cefaclor (compound 99638), cephradine, and cephalothinR N Jones, E H Gerlach, P C Fuchs
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 26, 2005
Antimicrobial activity of doripenem (S-4661): a global surveillance report (2003)T R Fritsche, M G Stilwell, R N Jones
Journal of Clinical Microbiology|February 1, 1994
Effects of blood medium supplements on activities of newer cephalosporins tested against enterococciB J Buschelman, R N Jones, M J Bale
Diagnostic Microbiology and Infectious Disease|February 11, 2000
In vitro evaluation of cefepime and other broad-spectrum beta-lactams for isolates in Malaysia and Singapore medical centers. The Malaysia/Singapore Antimicrobial Resistance Study GroupD J Biedenbach, M T Lewis, R N Jones
Diagnostic Microbiology and Infectious Disease|February 11, 2000
In vitro evaluation of broad-spectrum beta-lactams in the philippines medical centers: role of fourth-generation cephalosporins. The Philippines Antimicrobial Resistance Study GroupD M Johnson, D J Biedenbach, R N Jones
Diagnostic Microbiology and Infectious Disease|March 15, 2001
Three independent yearly analyses of the spectrum and potency of metronidazole: a multicenter study of 1,108 contemporary anaerobic clinical isolatesM E Erwin, A M Fix, R N Jones
Diagnostic Microbiology and Infectious Disease|June 19, 2001
Activity of BMS284756 against 2,681 recent clinical isolates of Haemophilus influenzae and Moraxella catarrhalis: Report from The SENTRY Antimicrobial Surveillance Program (2000) in Europe, Canada and the United StatesD J Biedenbach, R N Jones, M A Pfaller, et al.
Pageof 95

Showing results (451-460 of 945) with videos related to

Sort By:
Pageof 95
Journal of Clinical Microbiology|April 1, 1992
Interpretive criteria for disk diffusion tests using 5-microgram cefdinir disks with rapidly growing clinical isolatesR N Jones, M E Erwin, B B Gooding
Diagnostic Microbiology and Infectious Disease|November 21, 1998
Activity of a broad-spectrum cephalosporin (Ro 48-8391) alone and in combination with two novel beta-lactamase inhibitors (Ro 48-5545 and Ro 48-8724)R N Jones, S A Marshall, D J Varnam
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 1, 1993
In vitro activity of E-4868, a new trifluoroquinolone, compared to six similar compoundsM S Barrett, R N Jones, M E Erwin
The Journal of Antibiotics|September 1, 1977
In vitro antimicrobial activity comparison of cefaclor (compound 99638), cephradine, and cephalothinR N Jones, E H Gerlach, P C Fuchs
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 26, 2005
Antimicrobial activity of doripenem (S-4661): a global surveillance report (2003)T R Fritsche, M G Stilwell, R N Jones
Journal of Clinical Microbiology|February 1, 1994
Effects of blood medium supplements on activities of newer cephalosporins tested against enterococciB J Buschelman, R N Jones, M J Bale
Diagnostic Microbiology and Infectious Disease|February 11, 2000
In vitro evaluation of cefepime and other broad-spectrum beta-lactams for isolates in Malaysia and Singapore medical centers. The Malaysia/Singapore Antimicrobial Resistance Study GroupD J Biedenbach, M T Lewis, R N Jones
Diagnostic Microbiology and Infectious Disease|February 11, 2000
In vitro evaluation of broad-spectrum beta-lactams in the philippines medical centers: role of fourth-generation cephalosporins. The Philippines Antimicrobial Resistance Study GroupD M Johnson, D J Biedenbach, R N Jones
Diagnostic Microbiology and Infectious Disease|March 15, 2001
Three independent yearly analyses of the spectrum and potency of metronidazole: a multicenter study of 1,108 contemporary anaerobic clinical isolatesM E Erwin, A M Fix, R N Jones
Diagnostic Microbiology and Infectious Disease|June 19, 2001
Activity of BMS284756 against 2,681 recent clinical isolates of Haemophilus influenzae and Moraxella catarrhalis: Report from The SENTRY Antimicrobial Surveillance Program (2000) in Europe, Canada and the United StatesD J Biedenbach, R N Jones, M A Pfaller, et al.
Pageof 95